Loading...

AGIO AGIOS PHARMACEUTICALS INC US FDA Inspections 8-K Filing

GS P

G

AGIOS PHARMACEUTICALS INC

(AGIO)

2025 8-K

Financial Results Announcement

2026 Milestones Announcement

Quarterly Results

Regulatory Compliance

Financial Statements

Earnings Releases

Financial Results

Director Resignation

2025 Milestones

Financial Results

Earnings Reports

Annual Meeting Results

Agreement for Sale of Earn-...

Earnings Reports

Earnings Report

Earnings Reports

Earnings Reports

Annual Meeting and Stockhol...

Management Changes

Earnings Reports

Departure and Election of D...

By-Law Amendment

Earnings Reports

External Links:

Agios Pharmaceuticals received FDA approval for an update to the prescribing information for PYRUKYND, highlighting liver injury risks in patients with a different condition treated at higher doses, requiring liver tests before and during treatment.

AI Assistant

AGIOS PHARMACEUTICALS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.